Clinical outcomes in high-hypoglycaemia-risk patients with type 2 diabetes switching to insulin glargine 300 U/mL versus a first-generation basal insulin analogue in the United States : Results from the DELIVER High Risk real-world study

Sullivan, SD; Freemantle, N; Gupta, RA; Wu, J; Nicholls, CJ; Westerbacka, J; Bailey, TS

Sullivan, SD (通讯作者)，Univ Washington, Sch Pharm, CHOICE Inst, Seattle, WA 98195 USA.

ENDOCRINOLOGY DIABETES & METABOLISM, 2022; 5 (1):

Abstract

Aims To compare 12-month clinical effectiveness of insulin glargine 300 units/mL (Gla-300) versus first-generation basal insulin analogues (BIAs) (ins......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索